Description

BSE announces listing of two series of Commercial Paper issued by Bajaj Financial Securities Limited with CRISIL A1+ and IND A1+ ratings, totaling Rs. 550 crores.

Summary

BSE has listed two new series of Commercial Paper issued by Bajaj Financial Securities Limited on private placement basis. The first series of Rs. 200 crores (4000 units) matures on December 31, 2025, and the second series of Rs. 350 crores (7000 units) matures on March 16, 2026. Both securities carry CRISIL A1+ and IND A1+ credit ratings. ICICI Bank Limited acts as the Issuing and Paying Agent for both instruments.

Key Points

  • Two Commercial Paper series listed on BSE Debt segment with effect from December 16, 2025
  • Series 1: 4000 units of Rs. 5 lakhs each (Total: Rs. 200 crores), Scrip Code: 730780, ISIN: INE01C314DW3
  • Series 2: 7000 units of Rs. 5 lakhs each (Total: Rs. 350 crores), Scrip Code: 730781, ISIN: INE01C314DT9
  • Both series rated CRISIL A1+ and IND A1+ indicating highest safety
  • Trading only in dematerialized form in standard denomination of Rs. 5 lakhs and multiples
  • Tick size: 1 paise
  • ICICI Bank Limited is the Issuing and Paying Agent

Regulatory Changes

No regulatory changes introduced. This is a standard listing notification.

Compliance Requirements

  • Trading members must trade these securities only in dematerialized form under the specified ISIN numbers
  • Trading shall be in standard denomination of Rs. 5 lakhs and multiples thereof
  • Adherence to tick size of 1 paise for price movements

Important Dates

  • Listing Date: December 16, 2025
  • Series 1 Allotment: December 15, 2025
  • Series 1 Redemption: December 31, 2025
  • Series 2 Allotment: December 15, 2025
  • Series 2 Redemption: March 16, 2026

Impact Assessment

Minimal market impact. This is a routine debt instrument listing affecting primarily institutional investors and debt market participants. The high credit ratings (A1+) indicate strong creditworthiness of Bajaj Financial Securities Limited. The short tenure (16 days for Series 1, 91 days for Series 2) suggests these are money market instruments for short-term funding. No impact expected on equity markets or retail investors.

Impact Justification

Routine listing of Commercial Paper with short tenure. Limited impact restricted to debt market participants and institutional investors.